News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
529,226 Results
Type
Article (52289)
Company Profile (140)
Press Release (476797)
Section
Business (145098)
Career Advice (2230)
Deals (22679)
Drug Delivery (63)
Drug Development (66909)
Employer Resources (116)
FDA (11795)
Job Trends (11113)
News (248414)
Policy (21102)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (8)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (1)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (2)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2766)
Academic (1)
Accelerated approval (4)
Adcomms (11)
Allergies (72)
Alliances (39802)
ALS (79)
Alzheimer's disease (1330)
Antibody-drug conjugate (ADC) (100)
Approvals (11837)
Artificial intelligence (217)
Autoimmune disease (17)
Automation (10)
Bankruptcy (163)
Best Places to Work (9003)
BIOSECURE Act (17)
Biosimilars (54)
Biotechnology (87)
Bladder cancer (53)
Brain cancer (26)
Breast cancer (222)
Cancer (1838)
Cardiovascular disease (126)
Career advice (1822)
Career pathing (25)
CAR-T (127)
Cell therapy (368)
Cervical cancer (17)
Clinical research (53552)
Collaboration (729)
Compensation (259)
Complete response letters (9)
COVID-19 (2182)
CRISPR (32)
C-suite (184)
Cystic fibrosis (83)
Data (1883)
Decentralized trials (2)
Denatured (10)
Depression (31)
Diabetes (209)
Diagnostics (5048)
Digital health (15)
Diversity (7)
Diversity, equity & inclusion (32)
Drug discovery (108)
Drug pricing (64)
Drug shortages (10)
Duchenne muscular dystrophy (69)
Earnings (51538)
Editorial (26)
Employer branding (16)
Employer resources (103)
Events (75739)
Executive appointments (585)
FDA (12775)
Featured Employer (42)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (8)
Funding (625)
Gene editing (77)
Generative AI (19)
Gene therapy (238)
GLP-1 (520)
Government (3203)
Grass and pollen (5)
Guidances (40)
Healthcare (14535)
Huntington's disease (14)
IgA nephropathy (18)
Immunology and inflammation (74)
Indications (24)
Infectious disease (2289)
Inflammatory bowel disease (115)
Inflation Reduction Act (5)
Influenza (44)
Intellectual property (79)
Interviews (416)
IPO (10889)
IRA (32)
Job creations (2508)
Job search strategy (1591)
Kidney cancer (7)
Labor market (24)
Layoffs (328)
Leadership (12)
Legal (3894)
Liver cancer (54)
Lung cancer (264)
Lymphoma (121)
Machine learning (4)
Management (39)
Manufacturing (210)
MASH (52)
Medical device (9060)
Medtech (9062)
Mergers & acquisitions (12283)
Metabolic disorders (484)
Multiple sclerosis (68)
NASH (14)
Neurodegenerative disease (69)
Neuropsychiatric disorders (12)
Neuroscience (1767)
NextGen: Class of 2025 (4646)
Non-profit (4036)
Northern California (2039)
Now hiring (26)
Obesity (228)
Opinion (195)
Ovarian cancer (70)
Pain (62)
Pancreatic cancer (64)
Parkinson's disease (138)
Partnered (19)
Patents (159)
Patient recruitment (87)
Peanut (41)
People (45934)
Pharmaceutical (40)
Pharmacy benefit managers (6)
Phase I (16914)
Phase II (23438)
Phase III (17641)
Pipeline (967)
Podcasts (30)
Policy (88)
Postmarket research (2180)
Preclinical (8073)
Press Release (70)
Prostate cancer (82)
Psychedelics (24)
Radiopharmaceuticals (215)
Rare diseases (272)
Real estate (4523)
Recruiting (42)
Regulatory (15571)
Reports (30)
Research institute (2561)
Resumes & cover letters (357)
Rett syndrome (4)
RNA editing (3)
RSV (28)
Schizophrenia (58)
Series A (104)
Series B (68)
Service/supplier (12)
Sickle cell disease (44)
Southern California (1764)
Special edition (13)
Spinal muscular atrophy (124)
Sponsored (24)
Startups (2804)
Stomach cancer (7)
Supply chain (43)
Tariffs (10)
The Weekly (20)
United States (17616)
Vaccines (555)
Venture capitalists (22)
Webinars (12)
Weight loss (128)
Women's health (21)
Worklife (12)
Date
Today (91)
Last 7 days (567)
Last 30 days (2194)
Last 365 days (27858)
2025 (7195)
2024 (28735)
2023 (32455)
2022 (43035)
2021 (46023)
2020 (42948)
2019 (35849)
2018 (27072)
2017 (25619)
2016 (24906)
2015 (29472)
2014 (22470)
2013 (19505)
2012 (19773)
2011 (20739)
2010 (18836)
Location
Africa (738)
Alabama (51)
Alaska (6)
Arizona (117)
Arkansas (11)
Asia (32767)
Australia (5871)
California (4627)
Canada (1528)
China (422)
Colorado (189)
Connecticut (238)
Delaware (124)
Europe (75983)
Florida (682)
Georgia (158)
Idaho (33)
Illinois (415)
India (21)
Indiana (222)
Iowa (6)
Japan (137)
Kansas (81)
Kentucky (16)
Louisiana (9)
Maine (26)
Maryland (706)
Massachusetts (3467)
Michigan (171)
Minnesota (246)
Mississippi (1)
Missouri (61)
Montana (23)
Nebraska (17)
Nevada (46)
New Hampshire (35)
New Jersey (1405)
New Mexico (27)
New York (1410)
North Carolina (772)
North Dakota (8)
Northern California (2039)
Ohio (169)
Oklahoma (14)
Oregon (24)
Pennsylvania (964)
Puerto Rico (5)
Rhode Island (19)
South America (887)
South Carolina (15)
South Dakota (1)
Southern California (1764)
Tennessee (67)
Texas (677)
Utah (121)
Virginia (119)
Washington D.C. (57)
Washington State (480)
West Virginia (2)
Wisconsin (50)
529,226 Results for "d e shaw research".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
D. E. Shaw Research Licenses First-in-Class Therapeutic for Immunological Diseases to Lilly
D. E. Shaw Research (DESRES) today announced that it has entered into an exclusive global license agreement with Eli Lilly and Company (Lilly) for the clinical development and commercialization of DESRES’s program of Kv1.3-targeted therapeutics for the treatment of various immunological and inflammatory diseases.
June 13, 2022
·
2 min read
Business
Christi Shaw, Former CEO of Kite, a Gilead Company, Appointed to Cellares Advisory Board to Advance Cell Therapy Manufacturing
Cellares, a leader in the automation of cell therapy manufacturing and the world’s first Integrated Development and Manufacturing Organization, announced the addition of Christi Shaw to its Advisory Board.
March 26, 2024
·
4 min read
Press Releases
Bruker Announces Introduction of Revolutionary d-DNP Polarizer for MRI Research and for Dynamic Nuclear Polarization Liquids NMR
April 2, 2025
·
4 min read
Press Releases
SpyGlass Pharma Appoints Chetan Pujara, Ph.D., as Chief Research & Development Officer
March 28, 2025
·
2 min read
Business
Evecxia Therapeutics Strengthens Board of Directors With Appointments of Allan L. Shaw and Elliot Ehrich
Evecxia Therapeutics, Inc. today announced the appointments of Allan L. Shaw and Elliot Ehrich, MD to its Board of Directors, bringing with them decades of leadership experience in the biopharmaceutical industry.
October 30, 2023
·
4 min read
Press Releases
Zenas BioPharma Appoints Lisa von Moltke, M.D., as Head of Research and Development and Chief Medical Officer
March 17, 2025
·
9 min read
Press Releases
Candel Therapeutics Appoints Renowned Pancreatic Cancer Expert, Elizabeth M. Jaffee, M.D., to Research Advisory Board
March 19, 2025
·
5 min read
Press Releases
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology
March 5, 2025
·
2 min read
Vaccines
Sanofi Hit With $250M Impairment After Scrapping J&J-Partnered
E. coli
Vaccine
Without providing specific data, Sanofi on Thursday announced that the experimental vaccine did not significantly prevent invasive
E. coli
disease versus placebo.
February 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
American Academy of Dermatology Awards Podium Presentation to Phio Pharmaceutical’s Clinical Research at 2025 Annual Meeting
Interim Results from clinical study for cutaneous carcinomas presented at Late-Breaking Research Session
March 10, 2025
·
5 min read
1 of 52,923
Next
